B

GLP-1 Stock Finder

2.90

Derivation Chain

Step 1 Novo Nordisk obesity drug competition intensifies
Step 2 Obesity medication supply instability and stockout issues
Step 3 Real-time pharmacy/clinic inventory availability service for patients

Problem

GLP-1 obesity medications like Wegovy and Mounjaro experience intermittent stockouts due to global supply instability. Patients on these medications need to secure their next injection on schedule, but when their regular pharmacy/clinic is out of stock, they must call multiple locations—averaging 3–5 calls and 1–2 hours. Gaps in dosing reduce efficacy and require an additional ramp-up period.

Solution

Pharmacies and obesity clinics register their GLP-1 medication inventory, and patients can search for nearby pharmacies with stock based on their medication and location, plus set restock alerts. Pharmacies receive demand forecast data to optimize their ordering timing.

Target: GLP-1 obesity medication patients (ages 20–50), pharmacies near obesity clinics (approximately 25,000 pharmacies nationwide, subset handling obesity drugs)
Revenue Model: Free for patients; Pharmacy/Clinic B2B: $29/month per pharmacy (inventory registration + demand analytics dashboard). Pharma company ad revenue (banners for new drug launches)
Ecosystem Role: Infrastructure
MVP Estimate: 2_weeks

NUMR-V Scores

N Novelty
3.0/5
U Urgency
4.0/5
M Market
3.0/5
R Realizability
2.0/5
V Validation
3.0/5
NUMR-V Scoring System
N Novelty1-5How uncommon the service is in market context.
U Urgency1-5How urgently users need this problem solved now.
M Market1-5Market size and growth potential from proxy indicators.
R Realizability1-5Buildability for a small team with realistic constraints.
V Validation1-5Validation signal quality from competition and demand data.
SaaS N=.15 U=.20 M=.15 R=.30 V=.20 Senior N=.25 U=.25 M=.05 R=.30 V=.15

Feasibility (65%)

Tech Complexity
24.0/40
Data Availability
20.6/25
MVP Timeline
20.0/20
API Bonus
0.0/15
Feasibility Breakdown
Tech Complexity/ 40Difficulty of core implementation stack.
Data Availability/ 25Practical availability and cost of required data.
MVP Timeline/ 20Expected time to ship a usable MVP.
API Bonus/ 15Bonus for viable public API leverage.

Market Validation (56/100)

Competition
8.0/20
Market Demand
9.4/20
Timing
16.0/20
Revenue Signals
7.5/15
Pick-Axe Fit
10.5/15
Solo Buildability
5.0/10
Validation Breakdown
Competition/ 20Signal quality from competitor landscape.
Market Demand/ 20Demand proxies from search and mention patterns.
Timing/ 20Fit with current shifts in tech, behavior, and regulation.
Revenue Signals/ 15Reference evidence for monetization viability.
Pick-Axe Fit/ 15How well the concept serves participants in a trend.
Solo Buildability/ 10Practicality for lean-team implementation.

Technical Requirements

Frontend [medium] Backend [medium]
Dashboard